지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.12
- 수록면
- 404 - 408 (5page)
- DOI
- https://doi.org/10.3904/kjm.2020.95.6.404
이용수
초록· 키워드
오류제보하기
Dapagliflozin is a recently developed oral anti-diabetic drug and SGLT2 inhibitor with well-known cardioprotective and renoprotective effects. Although a reduction of the glomerular filtration rate is induced by volume depletion and tubule-glomerular feedback during the early period after administering a SGLT2 inhibitor, the renal prognosis improves more with a decrease of proteinuria. However, the risk of acute kidney injury increases in heart failure and hypovolemia patients, and in those taking certain drugs, such as non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers, or diuretics. We report acute kidney injury after dapagliflozin administration in a diabetic patient with acute cerebral infarction accompanied by right hemiplegia, motor aphasia, and dysphagia.
목차
등록된 정보가 없습니다.
참고문헌 (9)
참고문헌 신청
Monica Reddy RP / 2016 / SGLT2 inhibitors in the management of type 2 diabetes / Endocrine 53:364~372
Wiviott SD / 2019 / Dapagliflozin and cardiovascular outcomes in type 2 diabetes / N Engl J Med 380:347~357
Fioretto P / 2016 / SGLT2 inhibitors and the diabetic kidney / Diabetes Care
Inzucchi SE / 2015 / SGLT-2 inhibitors and cardiovascular risk : proposed pathways and review of ongoing outcome trials / Diab Vasc Dis Res 12:90~100
Vasilakou D / 2013 / Sodiumglucose cotransporter 2 inhibitors for type 2 diabetes : a systematic review and meta-analysis / Ann Intern Med 159:262~274
Wiviott SD / 2019 / Dapagliflozin and cardiovascular outcomes in type 2 diabetes / N Engl J Med 380:347~357
Fioretto P / 2016 / SGLT2 inhibitors and the diabetic kidney / Diabetes Care
Inzucchi SE / 2015 / SGLT-2 inhibitors and cardiovascular risk : proposed pathways and review of ongoing outcome trials / Diab Vasc Dis Res 12:90~100
Vasilakou D / 2013 / Sodiumglucose cotransporter 2 inhibitors for type 2 diabetes : a systematic review and meta-analysis / Ann Intern Med 159:262~274
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Clinical studies of dapagliflozin in pediatric patients: a rapid review
Annals of Pediatirc Endocrinology & Metabolism
2022 .12
-
제 2형 당뇨병 환자에서 Dapagliflozin의 안전성 평가
병원약사회지
2019 .01
-
제2형 당뇨병 환자에서 Dapagliflozin이 혈당과 심혈관계질환 위험인자에 미치는 영향 및 안전성
한국임상약학회지
2017 .01
-
Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus
Journal of Obesity & Metabolic Syndrome
2017 .01
-
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
Endocrinology and Metabolism
2018 .01
-
Use of dapagliflozin in patients with advanced diabetic kidney disease
Kidney Research and Clinical Practice
2018 .01
-
Acute Kidney Injury
대한외과학회 학술대회 초록집
2018 .11
-
The association between acute kidney injury in renal infarction and progression to chronic kidney disease
Kidney Research and Clinical Practice
2016 .01
-
Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2022 .11
-
Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
Diabetes and Metabolism Journal
2021 .01
-
Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
Diabetes and Metabolism Journal
2024 .09
-
응급실로 내원한 신경색 환자의 임상적 특징: 만성 신부전 진행 예측인자로서 단백뇨의 의미와 유용성
대한응급의학회지
2023 .04
-
신증후군에 동반된 급성 뇌경색
Journal of Neurocritical Care
2016 .01
-
급성신손상의 원인과 치료
대한내과학회지
2019 .08
-
Metformin에 추가로 병용되는 SGLT2 inhibitors의 효능과 안전성에 관한 고찰
한국임상약학회지
2018 .01
-
Vitamin C-induced Acute Kidney Injury
전남의대학술지
2017 .01
-
Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure Treatment
Korean Circulation Journal
2021 .01
-
SGLT2 억제제와 만성콩팥병
대한내과학회지
2021 .12
-
Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711-7)
Diabetes and Metabolism Journal
2019 .01
-
Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711-7)
Diabetes and Metabolism Journal
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0